Citation, DOI, disclosures and article data
Citation:
Gaillard F, Knipe H, Jones J, Eosinophilic granulomatosis with polyangiitis (neurological manifestations). Reference article, Radiopaedia.org (Accessed on 05 May 2024) https://doi.org/10.53347/rID-169101
Disclosures:
At the time the article was created Frank Gaillard had the following disclosures:
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to
not be relevant to the changes that were made.
View Frank Gaillard's current disclosures
Disclosures:
At the time the article was last revised Henry Knipe had the following disclosures:
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to
not be relevant to the changes that were made.
View Henry Knipe's current disclosures
Neurological manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) are common, more often in patients who are ANCA positive and most frequently manifesting as peripheral neuropathy, although central nervous system involvement is also encountered 1,2.
For a general discussion, please refer to the main article on eosinophilic granulomatosis with polyangiitis.
Involvement of the peripheral nervous system is seen in approximately 50% of patients with EGPA, whereas central nervous system involvement is far less common seen only in approximately 5% of individuals 1.
Clinical presentation of neurological involvement will depend on the location and severity of involvement 1-4.
There are no specific features distinguishing the various neurological sequelae of involvement by EGPA from numerous other causes of the various manifestations 3,4. As such the imaging features will depend on the specific condition and are discussed separately (see above) and CNS vasculitis for futher details.
Treatment and prognosis
For a general discussion, please refer to the main article on eosinophilic granulomatosis with polyangiitis.
Central nervous system involvement by EGPA confirs a somewhat worse prognosis 1,4.
-
1. André R, Cottin V, Saraux J et al. Central Nervous System Involvement in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Report of 26 Patients and Review of the Literature. Autoimmun Rev. 2017;16(9):963-9. doi:10.1016/j.autrev.2017.07.007 - Pubmed
-
2. Emmi G, Bettiol A, Gelain E et al. Evidence-Based Guideline for the Diagnosis and Management of Eosinophilic Granulomatosis with Polyangiitis. Nat Rev Rheumatol. 2023. doi:10.1038/s41584-023-00958-w - Pubmed
-
3. Saito Y, Watanabe T, Hattori T, Jodo S. Intracranial Vasculitis in Eosinophilic Granulomatosis with Polyangiitis. Rheumatology (Oxford). 2018;57(12):2253. doi:10.1093/rheumatology/key178 - Pubmed
-
4. Liu S, Guo L, Fan X et al. Clinical Features of Central Nervous System Involvement in Patients with Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Cohort Study in China. Orphanet J Rare Dis. 2021;16(1):152. doi:10.1186/s13023-021-01780-x - Pubmed
Promoted articles (advertising)